Voyageur Pharmaceuticals Ltd. (OTCMKTS:VYYRF – Get Free Report) was the recipient of a significant increase in short interest in September. As of September 15th, there was short interest totaling 20,000 shares, an increase of 79,900.0% from the August 31st total of 25 shares. Based on an average trading volume of 62,123 shares, the short-interest ratio is currently 0.3 days.
Voyageur Pharmaceuticals Stock Up 17.4%
OTCMKTS:VYYRF traded up $0.02 on Thursday, reaching $0.11. The company’s stock had a trading volume of 30,000 shares, compared to its average volume of 28,282. The business’s 50-day moving average price is $0.15 and its two-hundred day moving average price is $0.10. Voyageur Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $1.03.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd. is a Canadian pharmaceutical company focused on developing and commercializing contrast media used in medical imaging. Its product portfolio is centered on barium sulfate and iodine-based contrast agents, which help healthcare professionals visualize structures within the body during diagnostic procedures such as X-rays, computed tomography scans and other imaging examinations.
The company’s activities include the development, regulatory advancement and potential commercialization of pharmaceutical-grade contrast media.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
